Miranda S Moore1, Angelica Bocour1. 1. 3649315939 Viral Hepatitis Program, Bureau of Communicable Disease, New York City Department of Health and Mental Hygiene, Queens, NY, USA.
Abstract
OBJECTIVE: Curative treatments for hepatitis C virus (HCV) infection are available, but access and barriers to treatment can delay initiation. We investigated the time to first negative RNA test result among people with HCV infection and examined differences by homeless status and whether people were tested at a correctional facility or substance use treatment facility. METHODS: We used surveillance data to identify New York City residents first reported with HCV infection during January 1, 2015-December 31, 2018, with ≥1 positive RNA test result during January 1, 2015-November 1, 2019. We used Kaplan-Meier survival analysis to determine the time from the first positive RNA test result to the first negative RNA test result, with right-censoring at date of death or November 1, 2019. We determined substance use treatment, incarceration, or homelessness by ordering facility name and address or from patient residential address. RESULTS: Of 13 952 people with an HCV RNA-positive test result first reported during 2015-2018, 6947 (49.8%) subsequently received an RNA-negative test result. Overall, 25% received an RNA-negative test result within 208 (95% CI, 200-216) days and 50% within 902 (95% CI, 841-966) days. Homelessness, incarceration, or substance use treatment was indicated for 4304 (30.9%) people, among whom 25% received an RNA-negative test result within 469 (95% CI, 427-520) days and <50% received an RNA-negative test result during the study period. CONCLUSIONS: Efforts to connect people to treatment should occur soon after diagnosis, especially for people who could benefit from hepatitis C care coordination.
OBJECTIVE: Curative treatments for hepatitis C virus (HCV) infection are available, but access and barriers to treatment can delay initiation. We investigated the time to first negative RNA test result among people with HCV infection and examined differences by homeless status and whether people were tested at a correctional facility or substance use treatment facility. METHODS: We used surveillance data to identify New York City residents first reported with HCV infection during January 1, 2015-December 31, 2018, with ≥1 positive RNA test result during January 1, 2015-November 1, 2019. We used Kaplan-Meier survival analysis to determine the time from the first positive RNA test result to the first negative RNA test result, with right-censoring at date of death or November 1, 2019. We determined substance use treatment, incarceration, or homelessness by ordering facility name and address or from patient residential address. RESULTS: Of 13 952 people with an HCV RNA-positive test result first reported during 2015-2018, 6947 (49.8%) subsequently received an RNA-negative test result. Overall, 25% received an RNA-negative test result within 208 (95% CI, 200-216) days and 50% within 902 (95% CI, 841-966) days. Homelessness, incarceration, or substance use treatment was indicated for 4304 (30.9%) people, among whom 25% received an RNA-negative test result within 469 (95% CI, 427-520) days and <50% received an RNA-negative test result during the study period. CONCLUSIONS: Efforts to connect people to treatment should occur soon after diagnosis, especially for people who could benefit from hepatitis C care coordination.
Entities:
Keywords:
RNA-negative timing; hepatitis C virus; homelessness; incarceration; substance use treatment
Authors: Anna Palmer; Timothy Papaluca; Mark Stoové; Rebecca Winter; Alisa Pedrana; Margaret Hellard; David Wilson; Alexander Thompson; Nick Scott Journal: Int J Drug Policy Date: 2021-03-18
Authors: Sarah Morey; Abi Hamoodi; Dee Jones; Tina Young; Craig Thompson; Julie Dhuny; Emma Buchanan; Carolyn Miller; Margaret Hewett; Manoj Valappil; Ewan Hunter; Stuart McPherson Journal: J Viral Hepat Date: 2018-11-28 Impact factor: 3.728
Authors: Melissa R Stein; Irene J Soloway; Karen S Jefferson; Robert J Roose; Julia H Arnsten; Alain H Litwin Journal: J Subst Abuse Treat Date: 2012-10-02
Authors: Cheryl J Ho; Charles Preston; Kim Fredericks; Sara L Doorley; Richard J Kramer; Lawrence Kwan; Ahmad Kamal Journal: J Addict Med Date: 2013 Sep-Oct Impact factor: 3.702
Authors: Kimberly Page; Michelle Yu; Jennifer Cohen; Jennifer Evans; Martha Shumway; Elise D Riley Journal: BMC Public Health Date: 2017-02-07 Impact factor: 3.295